Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mizagliflozin Phase II in Chronic Idiopathic Constipation
NCT01600001Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mizagliflozin in chronic idiopathic constipation (CIC), sponsored by Kissei Pharmaceutical Co., Ltd.. Status: completed.
02
Drugs
mizagliflozin
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT01600001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01600001.